Please login to the form below

Not currently logged in
Email:
Password:

Bayer announces new leadership

New CEO and CFO will take over in 2010

Dr Marijn E Dekkers, current president and chief executive officer (CEO) of Thermo Fisher Scientific, will succeed Werner Wenning as CEO at Bayer from October 1 2010. Dekkers will join the Bayer management board on January 1 2010. He will also serve as interim CEO of Bayer HealthCare, succeeding Arthur J Higgins who will leave the company during the first half of 2010 for personal reasons.

Werner Baumann will become chief financial officer (CFO) following the annual stockholders' meeting on April 30 2010, when the present CFO, Klaus Kühn, takes early retirement. Baumann is currently a member of both the management board and executive committee of Bayer HealthCare, and will also join the Bayer management board on January 1 2010.

Werner Wenning will extend his contract of service to September 30 2010.

"Mr Wenning has very successfully steered our company for the past seven years. We are grateful to him for consenting to extend his contract of service, thereby ensuring both continuity and an adequate period of transition in these economically difficult times," stated Dr Manfred Schneider, chairman of the Bayer supervisory board. "The supervisory board believes that, in Dr Dekkers, it has found a highly qualified successor to steer the fortunes of our company. His international experience, goal-oriented approach and proven management skills are very convincing qualities."

16th September 2009

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield Commercial & Medical Services

Ashfield Commercial & Medical Services, part of UDG Healthcare plc, is a leading international provider of services to healthcare manufactures...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...